相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Basal-Like Breast Cancer Update on Clinicopathologic, Immunohistochemical, and Molecular Features
Jennifer Leidy et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2014)
Suppression of triple-negative breast cancer metastasis by pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT master regulators
Lyndsay V. Rhodes et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Expression of LRIG1 is associated with good prognosis and human papillomavirus status in oropharyngeal cancer
D. Lindquist et al.
BRITISH JOURNAL OF CANCER (2014)
CUL4A Induces Epithelial-Mesenchymal Transition and Promotes Cancer Metastasis by Regulating ZEB1 Expression
Yunshan Wang et al.
CANCER RESEARCH (2014)
Loss of LRIG1 Locus Increases Risk of Early and Late Relapse of Stage I/II Breast Cancer
Patricia A. Thompson et al.
CANCER RESEARCH (2014)
MET is a potential target for use in combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer
Yu Jin Kim et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
LRIG1 inhibits STAT3-dependent inflammation to maintain corneal homeostasis
Takahiro Nakamura et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Cbl-independent degradation of Met: ways to avoid agonism of bivalent Met-targeting antibody
J. M. Lee et al.
ONCOGENE (2014)
LRIG1 modulates aggressiveness of head and neck cancers by regulating EGFR-MAPK-SPHK1 signaling and extracellular matrix remodeling
J. J-C Sheu et al.
ONCOGENE (2014)
Architecture of tight junctions and principles of molecular composition
Christina M. Van Itallie et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2014)
Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer
Christine Mehner et al.
ONCOTARGET (2014)
Membrane-Initiated Estradiol Signaling of Epithelial-Mesenchymal Transition-Associated Mechanisms Through Regulation of Tight Junctions in Human Breast Cancer Cells
Javier E. Jimenez-Salazar et al.
HORMONES & CANCER (2014)
LRIG1 is a triple threat: ERBB negative regulator, intestinal stem cell marker and tumour suppressor
Y. Wang et al.
BRITISH JOURNAL OF CANCER (2013)
Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Ala and MAPK pathways
Jaemoo Chun et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2013)
Leucine-rich Repeat and Immunoglobulin Domain-containing Protein-1 (Lrigl) Negative Regulatory Action toward ErbB Receptor Tyrosine Kinases Is Opposed by Leucine-rich Repeat and Immunoglobulin Domain-containing Protein 3 (Lrig3)
Hanine Rafidi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Restoration of LRIG1 suppresses bladder cancer cell growth by directly targeting EGFR activity
Lei Chang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2013)
LRIG1 regulates cadherin-dependent contact inhibition directing epithelial homeostasis and pre-invasive squamous cell carcinoma development
Liwen Lu et al.
JOURNAL OF PATHOLOGY (2013)
Lrig2-Deficient Mice Are Protected against PDGFB-Induced Glioma
Veronica Rondahl et al.
PLOS ONE (2013)
bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer
Pascal Jezequel et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Molecular insights on basal-like breast cancer
Mev Dominguez Valentin et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer
N. P. A. Devika Gunasinghe et al.
CANCER AND METASTASIS REVIEWS (2012)
LRIG1 Modulates Cancer Cell Sensitivity to Smac Mimetics by Regulating TNFα Expression and Receptor Tyrosine Kinase Signaling
Longchuan Bai et al.
CANCER RESEARCH (2012)
Suppression of the Epithelial-Mesenchymal Transition by Grainyhead-like-2
Benjamin Cieply et al.
CANCER RESEARCH (2012)
The Pan-ErbB Negative Regulator Lrig1 Is an Intestinal Stem Cell Marker that Functions as a Tumor Suppressor
Anne E. Powell et al.
CELL (2012)
c-Myb regulates matrix metalloproteinases 1/9, and cathepsin D: implications for matrix-dependent breast cancer cell invasion and metastasis
Lucia Knopfova et al.
MOLECULAR CANCER (2012)
Lrig1 controls intestinal stem-cell homeostasis by negative regulation of ErbB signalling
Vivian W. Y. Wong et al.
NATURE CELL BIOLOGY (2012)
Overexpression of c-Met promotes invasion and metastasis of small oral tongue carcinoma
Young Chang Lim et al.
ORAL ONCOLOGY (2012)
The T Box Transcription Factor TBX2 Promotes Epithelial-Mesenchymal Transition and Invasion of Normal and Malignant Breast Epithelial Cells
Bin Wang et al.
PLOS ONE (2012)
Met Receptor Acts Uniquely for Survival and Morphogenesis of EGFR-Dependent Normal Mammary Epithelial and Cancer Cells
Paolo Accornero et al.
PLOS ONE (2012)
Cardiotoxin III suppresses MDA-MB-231 cell metastasis through the inhibition of EGF/EGFR-mediated signaling pathway
Pei-Chien Tsai et al.
TOXICON (2012)
A Gene Signature for Predicting Outcome in Patients with Basal-like Breast Cancer
Robin M. Hallett et al.
SCIENTIFIC REPORTS (2012)
Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met
Kelly L. Mueller et al.
BREAST CANCER RESEARCH (2012)
Epithelial-mesenchymal transition, cancer stem cells and treatment resistance
Bhuvanesh Dave et al.
BREAST CANCER RESEARCH (2012)
Lrig1 Is an Estrogen-Regulated Growth Suppressor and Correlates with Longer Relapse-Free Survival in ERα-Positive Breast Cancer
Sheryl R. Krig et al.
MOLECULAR CANCER RESEARCH (2011)
Synergistic Effects of Foretinib with HER-Targeted Agents in MET and HER1-or HER2-Coactivated Tumor Cells
Li Liu et al.
MOLECULAR CANCER THERAPEUTICS (2011)
An EMT-Driven Alternative Splicing Program Occurs in Human Breast Cancer and Modulates Cellular Phenotype
Irina M. Shapiro et al.
PLOS GENETICS (2011)
A clinically relevant gene signature in triple negative and basal-like breast cancer
Achim Rody et al.
BREAST CANCER RESEARCH (2011)
Identifying common prognostic factors in genomic cancer studies: A novel index for censored outcomes
Sigrid Rouam et al.
BMC BIOINFORMATICS (2010)
Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer
H. Nalwoga et al.
BRITISH JOURNAL OF CANCER (2010)
Tyrosine Phosphorylation Profiling Reveals the Signaling Network Characteristics of Basal Breast Cancer Cells
Falko Hochgraefe et al.
CANCER RESEARCH (2010)
The met receptor tyrosine kinase and basal breast cancer
Marisa G. Ponzo et al.
CELL CYCLE (2010)
Epithelial-Mesenchymal Transition (EMT) in Tumor-Initiating Cells and Its Clinical Implications in Breast Cancer
Chad J. Creighton et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2010)
Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition
Yvonne L. Chao et al.
MOLECULAR CANCER (2010)
ARQ 197, a Novel and Selective Inhibitor of the Human c-Met Receptor Tyrosine Kinase with Antitumor Activity
Neru Munshi et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Mesenchymal/Stromal Gene Expression Signature Relates to Basal-Like Breast Cancers, Identifies Bone Metastasis and Predicts Resistance to Therapies
Cristina Marchini et al.
PLOS ONE (2010)
The Met oncogene and basal-like breast cancer: another culprit to watch out for?
Stefania Gastaldi et al.
BREAST CANCER RESEARCH (2010)
Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics
Bryan T. Hennessy et al.
CANCER RESEARCH (2009)
Lrig1 Expression Defines a Distinct Multipotent Stem Cell Population in Mammalian Epidermis
Kim B. Jensen et al.
CELL STEM CELL (2009)
Epidermal stem cell diversity and quiescence
Fiona M. Watt et al.
EMBO MOLECULAR MEDICINE (2009)
Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer
Marisa G. Ponzo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Kornelia Polyak et al.
NATURE REVIEWS CANCER (2009)
Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype
David Sarrió et al.
CANCER RESEARCH (2008)
Suppression of the Negative Regulator LRIG1 Contributes to ErbB2 Overexpression in Breast Cancer
Jamie K. Miller et al.
CANCER RESEARCH (2008)
Direct evidence for epithelial-mesenchymal transitions in breast cancer
Anthony J. Trimboli et al.
CANCER RESEARCH (2008)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Lrig1 is an endogenous inhibitor of ret receptor tyrosine kinase activation, downstream signaling, and biological responses to GDNF
Fernanda Ledda et al.
JOURNAL OF NEUROSCIENCE (2008)
LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIII
M. A. Stutz et al.
ONCOGENE (2008)
The CD44(+)/CD24(-) phenotype is enriched in basal-like breast tumors
Gabriella Honeth et al.
BREAST CANCER RESEARCH (2008)
The transcription factor ZEB1 (δEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity
K. Aigner et al.
ONCOGENE (2007)
LRIG1 is a novel negative regulator of the Met receptor and opposes met and Her2 synergy
David L. Shattuck et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
LRIG-inhibitors of growth factor signalling - double-edged swords in human cancer?
Hakan Hedman et al.
EUROPEAN JOURNAL OF CANCER (2007)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve et al.
CANCER CELL (2006)
Single-cell expression profiling of human epidermal stem and transit-amplifying cells: Lrig1 is a regulator of stem cell quiescence
Kim B. Jensen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Epithelial-mesenchymal transition in development and cancer:: role of phosphatidylinositol 3′ kinase/AKT pathways
L Larue et al.
ONCOGENE (2005)
The fallacy of epithelial mesenchymal transition in neoplasia
D Tarin
CANCER RESEARCH (2005)
LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation
G Gur et al.
EMBO JOURNAL (2004)
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
J Yang et al.
CELL (2004)
The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases
MB Laederich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures
J Debnath et al.
METHODS (2003)
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
G Dontu et al.
GENES & DEVELOPMENT (2003)
Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts
F Wang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Targeted disruption of LIG-1 gene results in psoriasiform epidermal hyperplasia
Y Suzuki et al.
FEBS LETTERS (2002)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Cloning, characterization, and expression of human LIG1
J Nilsson et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
分享论文
